Dr. Mark M. Mckenzie

Internal Medicine
Office
6035 Shallowford Rd Ste 109, 
Chattanooga, TN 
Office
6035 Shallowford Rd Ste 109, 
Chattanooga, TN 

Overview

Mark Mckenzie is a primary care provider, practicing in Internal Medicine in Chattanooga, Tennessee.

His clinical expertise encompasses Miller-Fisher Syndrome, Chronic Polyradiculoneuritis, Guillain-Barre Syndrome, and Athlete's Foot.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 19 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in TN

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO

Locations

Office
6035 Shallowford Rd Ste 109, Chattanooga, TN 37421

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Completed
Publish Date: August 19, 2026
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
Enrollment Status: Completed
Publish Date: April 13, 2026
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: December 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Patients With Celiac Disease (ACeD)
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Patients With Celiac Disease (ACeD)
Enrollment Status: Completed
Publish Date: August 06, 2024
Intervention Type: Drug
Study Drug: KAN-101
Study Phase: Phase 1
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

3 Total Publications

Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assays.
Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assays.
Journal: Microbiology spectrum
Published: February 11, 2025
Similar Doctors
Expertise in
68
conditions
Dr. Chirag M. Patel
Internal Medicine
Expertise in
68
conditions
Dr. Chirag M. Patel
Internal Medicine

Office

7425 Ziegler Rd Ste 143, 
Chattanooga, TN 
 (1.0 miles away)
423-778-7537
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Chirag Patel is a primary care provider, practicing in Internal Medicine in Chattanooga, Tennessee. Dr. Patel is highly rated in 68 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatic Cystic Hamartoma, Caroli Disease, and Banti's Syndrome. Dr. Patel is currently accepting new patients.

Expertise in
70
conditions
Dr. Asma S. Khan
Internal Medicine
Expertise in
70
conditions
Dr. Asma S. Khan
Internal Medicine

Anesthesia Services Associates PLLC

1726 Gunbarrel Rd Ste 100, 
Chattanooga, TN 
 (0.1 miles away)
423-954-9010
Languages Spoken:
English, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Asma Khan is a primary care provider, practicing in Internal Medicine in Chattanooga, Tennessee. Dr. Khan is highly rated in 70 conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Storm, and Hyperthyroidism. Dr. Khan is currently accepting new patients.

Expertise in
20
conditions
Dr. Donald P. Hetzel
Internal Medicine
Expertise in
20
conditions
Dr. Donald P. Hetzel
Internal Medicine

Surgical Specialists P.C.

4700 Battlefield Pkwy Ste 130, 
Ringgold, GA 
 (8.9 miles away)
423-698-8101
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Donald Hetzel is a primary care provider, practicing in Internal Medicine in Ringgold, Georgia. Dr. Hetzel is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Angiodysplasia of the Colon, Diverticular Disease, Colonoscopy, and Endoscopy. Dr. Hetzel is currently accepting new patients.

Frequently Asked Questions about Dr. Mark M. Mckenzie

How do I make an appointment with Dr. Mark M. Mckenzie?

You can book an appointment with Dr. Mark M. Mckenzie by calling their office at 423-698-4584. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark M. Mckenzie a top-rated expert for Miller-Fisher Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark M. Mckenzie is classified as an Experienced expert for Miller-Fisher Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark M. Mckenzie specialize in?

While Dr. Mark M. Mckenzie is a Internal Medicine, they have specific expertise in Miller-Fisher Syndrome, Chronic Polyradiculoneuritis, and Guillain-Barre Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Mark M. Mckenzie participate in research or clinical trials?

Yes. Dr. Mark M. Mckenzie has published 3 articles and abstracts on conditions like Miller-Fisher Syndrome. You can view a list of Dr. Mark M. Mckenzie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark M. Mckenzie accept my insurance?

Dr. Mark M. Mckenzie accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 423-698-4584 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mckenzie's expertise for a condition
ConditionClose
        View All 21 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile